Avalon GloboCare Corp.: Diferență între versiuni
The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).
Admin (discuție | contribuții) (Pagină nouă: Pagina dedicata companiei Avalon GloboCare Corp. listata cu simbolurile US.ALBT, US.AVCO ==Descriere companie== Avalon GloboCare Corp. (www.avalon-globocare.com) is a clinical-stage, vertically integrated, CellTech bio-developer company. The Company is focused on the fields of cellular immunotherapy, including CAR-T/NK; exosome technology (ACTEX), and COVID-19-related vaccine and therapeutics through its subsidiaries. It operates through two business segments: real property...) |
(The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).) |
||
| Linia 2: | Linia 2: | ||
==Descriere companie== | ==Descriere companie== | ||
Avalon GloboCare Corp. (www.avalon-globocare.com) is a clinical-stage, vertically integrated, CellTech bio-developer company. The Company is focused on the fields of cellular immunotherapy, including CAR-T/NK; exosome technology (ACTEX), and COVID-19-related vaccine and therapeutics through its subsidiaries. It operates through two business segments: real property operating segment and medical related consulting services segment. The Company also provides strategic advisory and outsourcing services to facilitate and improve its clients’ growth and development, as well as competitiveness in healthcare and CellTech industry markets. Its downstream medical team and facility consists of affiliated hospital networks and experts specialized in hematology, oncology, cellular immunotherapy, hematopoietic stem/progenitor cell transplant, as well as regenerative therapeutics. Its clinical programs include AVA-001, ACTEX, FLASH-CAR, and AVA-Trap. | Avalon GloboCare Corp. (www.avalon-globocare.com) is a clinical-stage, vertically integrated, CellTech [[BIO|bio]]-developer company. The Company is focused on the fields of cellular immunotherapy, including CAR-T/NK; exosome technology (ACTEX), and COVID-19-related vaccine and therapeutics through its subsidiaries. It operates through two business segments: real property operating segment and medical related consulting services segment. The Company also provides strategic advisory and outsourcing services to facilitate and improve its clients’ growth and development, as well as competitiveness in healthcare and CellTech industry markets. Its downstream medical team and facility consists of affiliated hospital networks and experts specialized in hematology, oncology, cellular immunotherapy, hematopoietic stem/progenitor cell transplant, as well as regenerative therapeutics. Its clinical programs include AVA-001, ACTEX, FLASH-CAR, and AVA-Trap. | ||
==Grafic actiuni companie== | ==Grafic actiuni companie== | ||